← Open Payments lookup

IRIS GRETT: Open Payments

NPI 1801106828 · KINGSTON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,035 in 58 payments from 11 companies in 2025. Trend: 2023 $790 · 2024 $935 · 2025 $1,035

Food & beverage: $1,035
CompanyPaymentsAmount
ABBVIE INC.32$414
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$236
Alkermes, Inc.3$69
Otsuka America Pharmaceutical, Inc.3$59
E.R. Squibb & Sons, L.L.C.3$59
Supernus Pharmaceuticals, Inc.3$58
Takeda Pharmaceuticals U.S.A., Inc.2$45
Neurocrine BioSciences, Inc.1$34
Biogen, Inc.1$24
Vanda Pharmaceuticals Inc.1$20

Products named: VRAYLAR, CAPLYTA, REXULTI, COBENFY, Qelbree, TRINTELLIX, ARISTADA, INGREZZA.

Industry payments across NY — which companies pay providers there.